Acrinova AB (ACRI-A) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Acrinova AB SEK 18.50, price SEK 8.16, upside +126.7%, quality 61 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Acrinova AB for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range kr 4.19 – kr 11.40 · fair‑value band kr 12.21 – kr 27.33 · the kr 8.16 price screens below the kr 18.50 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Oct 3, 2026.
Follow Acrinova in your weekly email
Every Wednesday you see whether Acrinova is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Acrinova AB (publ), a real estate company, owns, develops, and manages real estate properties in Sweden. Its property portfolio includes trade and service, warehouse and production, and residential properties, as well as logistics/production, housing, shop, industrial and commercial premises, restaurant, and office.
Show more
Acrinova AB (publ), a real estate company, owns, develops, and manages real estate properties in Sweden. Its property portfolio includes trade and service, warehouse and production, and residential properties, as well as logistics/production, housing, shop, industrial and commercial premises, restaurant, and office. The company was incorporated in 2014 and is headquartered in Malmö, Sweden.
Stock analysis
Acrinova AB (ACRI-A) currently trades at kr 8.16, while our model-based Fair Value estimate is kr 18.50, implying the stock looks roughly 55.9% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of kr 163.32 per share, and 13 of the 13 models we run sit above the kr 8.16 price.
Bear case: the Asset-Based group reads lowest at kr 8.60, and 0 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: kr 12.21 (bear) to kr 27.33 (bull), the price of kr 8.16 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 61/100 (solid quality), in the Real Estate sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Acrinova AB reported revenue of 128M SEK in FY2025 versus 102M SEK in FY2021, a compound +5.9%/yr. Reported net income was 60.0M SEK in FY2025, compounding −20.9%/yr from FY2021.
Key figures
Market cap 355M SEK (≈ $35.4M) · P/E ratio 12.9 · P/S ratio 6.02 · EPS (TTM) kr 0.6200 · Net margin 46.8% · Return on equity 5.4% · Return on assets (EBIT) 5.4% · Operating margin 32.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −48% fair-value upside, at 127%, ACRI-A screens cheaper than that median.
Fair Value models
Bear kr 12.21Fair Value kr 18.50Bull kr 27.33
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.57/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−19.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
Start year 2020 (pandemic). Over 10 years: +37.6% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+35.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
−6.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−6.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.8.6% vs 11.3%, steady
Profit margin 2019 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.58% → 57%
2025 sits 80% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate - Diversified · 129 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score63 · Top 25%
Fair Value upside+126.7% · Top 25%
Profitability
Return on equity (TTM)5.4% · Above median
Return on assets0.7% · Below median
Net margin (TTM)50.2% · Top 25%
Operating margin (TTM)32.9% · Above median
Growth and dividend
Revenue growth−68.7% · Bottom 25%
Dividend yield (TTM)48.7% · Top 25%
Balance sheet
Debt / equity0.61× · Above median
Valuation Multiplesvs Real Estate - Diversified median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Acrinova AB Fair Value". https://www.fairvalue-calculator.com/stock/ACRI-A
Frequently asked questions
Is Acrinova AB (ACRI-A) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of kr 18.50 versus a price of kr 8.16, about +127% upside (undervalued).
What is the fair value of ACRI-A?
Our model-based fair value for Acrinova AB is kr 18.50 (as of Oct 3, 2026), built from audited fundamentals. The current price: kr 8.16.
What is the quality score of ACRI-A?
Acrinova AB has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Acrinova AB (ACRI-A)?
Our model-based price target is the fair value of kr 18.50 (as of Oct 3, 2026) from 13 valuation models. Cautious scenario kr 12.21, optimistic scenario kr 27.33. It is a calculation from audited fundamentals, not an analyst target.
What is the Acrinova AB stock forecast for 2026?
Our models put fair value at kr 18.50, about +127% upside versus a price of kr 8.16 (undervalued). Cautious scenario kr 12.21, optimistic scenario kr 27.33. The calculation is refreshed regularly with new filings.
What is the revenue of Acrinova AB (ACRI-A)?
Acrinova AB reported trailing-twelve-month revenue of about 72.1M SEK (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Acrinova AB (ACRI-A)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Acrinova AB it is kr 18.50 per share (as of Oct 3, 2026), against a price of kr 8.16. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Acrinova AB stock overvalued or undervalued in 2026?
As of Oct 3, 2026, ACRI-A trades below its calculated fair value: price kr 8.16, fair value kr 18.50, a gap of about +127% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ACRI-A?
No. The price is what the market pays today (kr 8.16); the fair value is what the company's own numbers justify (kr 18.50). For Acrinova AB the two are kr 10.34 per share apart. That gap is exactly why we show both numbers side by side.
How much is Acrinova AB worth?
The market values Acrinova AB at about 355M SEK (market capitalisation, as of Oct 3, 2026). Per share that is kr 8.16; our models calculate a fair value of kr 18.50 per share.
What do the bullish and bearish scenarios say about ACRI-A?
Our models span a range for Acrinova AB: cautious scenario kr 12.21, base kr 18.50, optimistic kr 27.33 per share (as of Oct 3, 2026, price kr 8.16). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ACRI-A?
Acrinova AB trades at a price-to-earnings ratio of 12.9 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 18.50 is built from several models across several years. Other multiples: P/B 0.6, P/S 4.9, EV/EBITDA 30.1.
How solid is the balance sheet of Acrinova AB (ACRI-A)?
Balance-sheet figures for Acrinova AB (as of Oct 3, 2026): return on equity 5.4%, debt of 0.61 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is ACRI-A from its 52-week high?
Acrinova AB trades at kr 8.16, about 28% below its 52-week high of kr 11.40 and 12% above the low of kr 7.26 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of kr 18.50 is for.
Which stocks are comparable to Acrinova AB?
From the same area (Real Estate) we also value Henderson Land Development Company, Swiss Prime Site AG, Central Pattana Public Company, The Phoenix Mills Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Acrinova AB stock attractive at the current price?
The data as of Oct 3, 2026: price kr 8.16, calculated fair value kr 18.50 (+127%), Quality Score 61/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ACRI-A calculated?
We run Acrinova AB through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 18.50, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Acrinova AB currently trades 56 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Acrinova AB (ACRI-A)?
The closing price on Oct 2, 2026 was kr 8.16. Our model-based fair value is kr 18.50, about +127% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Acrinova AB right now?
The price is below even our cautious bear case (kr 12.21). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (61/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (kr 12.21 to kr 27.33) leaves room in how you read the outcome.
Key figures of Acrinova AB
How large is the market capitalisation of Acrinova AB (ACRI-A)?
The market capitalisation of Acrinova AB is 355M SEK (≈ $35.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Acrinova AB (ACRI-A)?
The price-to-sales ratio of Acrinova AB is 6.02 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Acrinova AB (ACRI-A)?
Earnings per share at Acrinova AB are kr 0.6200 (price ÷ EPS = P/E 12.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Acrinova AB (ACRI-A)?
The net margin of Acrinova AB is 46.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Acrinova AB (ACRI-A)?
The return on equity (ROE) of Acrinova AB is 5.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Acrinova AB (ACRI-A)?
On an EBIT basis the return on assets of Acrinova AB is 5.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Acrinova AB (ACRI-A)?
The operating margin of Acrinova AB is 32.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Acrinova AB (ACRI-A)?
Revenue at Acrinova AB is growing −68.7% versus a year earlier (3y avg −0.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Acrinova AB (ACRI-A)?
Earnings per share at Acrinova AB are growing −94.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Acrinova AB (ACRI-A) generate?
The free cash flow of Acrinova AB is 251M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Acrinova AB (ACRI-A) carry?
The net debt of Acrinova AB is 250M SEK (fiscal year 2025, ≈ 1.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Acrinova AB in the live analysis
One click puts Acrinova AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
